PT 141 also known by its generic name Bremelanotide, is a synthetic peptide developed to treat sexual dysfunction in both men and women. It’s most commonly used to enhance libido and sexual arousal, particularly in individuals with low sexual desire or arousal disorders. Unlike drugs like Viagra or Cialis that work primarily on blood flow, PT 141 works directly on the brain’s arousal centers by activating melanocortin receptors (especially MC-4 and MC-3).
Mechanism of Action
PT 141 is a melanocortin receptor agonist, derived from the peptide hormone Melanotan II. It targets the central nervous system (CNS) rather than the vascular system, stimulating regions in the brain associated with arousal. This makes it effective for both men and women, even in the absence of underlying physical causes of dysfunction.
Key Benefits
- Increases sexual desire and libido
- Effective for both men and women
- Can help with erectile dysfunction (ED) and female sexual arousal disorder (FSAD)
- Acts within 30–60 minutes
- Does not rely on nitric oxide pathways or blood vessel dilation
Common Forms
- Injection (Subcutaneous): Most effective and widely used
- Nasal Spray (less common, used in research contexts)
- Not typically taken orally due to low bioavailability
Possible Side Effects
- Nausea
- Flushing
- Headache
- Vomiting (at higher doses)
- Injection site reactions (redness, irritation)
Usage Notes
- Typically administered 30 to 60 minutes before sexual activity
- Effects can last up to 6–12 hours
- Should be used under medical supervision, especially for those with cardiovascular concerns
Regulatory Status
- FDA-approved under the brand name Vyleesi for treating hypoactive sexual desire disorder (HSDD) in premenopausal women
- Still considered experimental or off-label for other uses, including male ED or libido enhancement outside FDA-approved indications
Who Uses PT 141?
- Men who don’t respond well to PDE5 inhibitors (e.g., Viagra)
- Women with low sexual desire not caused by medical or psychiatric conditions
- Couples seeking enhanced intimacy or addressing mismatched libidos
PT 141, also known as Bremelanotide, is a synthetic peptide hormone that has gained significant attention in recent years due to its potential to treat sexual dysfunction in both men and women. This peptide is synthesized using solid-phase synthesis methods, which involve selectively protecting part of the amino acids and adopting different cyclization sequences to obtain the cyclopeptide resin.
Structure and Modifications
PT 141 is a cyclic heptapeptide with the amino acid sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH. This peptide is a synthetic version of the naturally occurring alpha-melanocyte-stimulating hormone (α-MSH), which regulates various physiological processes in the body, such as appetite, immune function, and sexual behavior.
Synthesis and Research
PT 141 is synthesized using solid-phase synthesis methods, which involve selectively protecting part of the amino acids and adopting different cyclization sequences to obtain the cyclopeptide resin. Research on PT-141 has focused on its pharmacokinetic and pharmacodynamic effects. Studies have shown that it binds to melanocortin receptors, particularly MC1R and MC4R, which are expressed primarily in the central nervous system.
Pharmacokinetics and Pharmacodynamics
PT 141 works by stimulating melanocortin receptors in the brain, which leads to the release of nitric oxide. The peptide has been found to stimulate the release of nitric oxide, leading to increased blood flow and relaxation of smooth muscles.
PT 141 Side Effects
PT 141 (Bremelanotide), while effective for enhancing sexual arousal in both men and women, can cause a range of mild to moderate side effects, especially at higher doses or with repeated use. Understanding these potential effects is crucial before starting treatment.
Most Common Side Effects
These typically occur shortly after administration and often resolve on their own:
- Nausea
The most frequently reported side effect. Often dose-dependent and more common in women. May require anti-nausea medication in some cases. - Flushing or Warm Sensation
Temporary redness or warmth, especially in the face, neck, or chest. - Headache
Can range from mild to moderate. Often reported in early use and may diminish over time. - Injection Site Reactions (for subcutaneous use)
Includes redness, itching, bruising, or mild pain where the shot was administered.
Less Common Side Effects
These are less frequent but may still occur:
- Vomiting
Usually tied to higher doses or poor tolerance. Often manageable with supportive care. - Increased Blood Pressure
PT-141 can cause temporary spikes in blood pressure and should be used cautiously in people with cardiovascular conditions. - Darkening of Gums or Skin (Hyperpigmentation)
Rare but possible, especially with repeated use or in those with darker skin tones. - Nasal Congestion
Occasional in nasal spray formulations, though this form is less common.
When to Seek Medical Advice
Seek immediate medical help if you experience:
- Chest pain or palpitations
- Persistent high blood pressure
- Severe allergic reaction (rash, itching, swelling)
- Fainting or dizziness that doesn’t resolve
Safety Warnings
- Not recommended for people with uncontrolled hypertension or heart disease
- Not studied in pregnant or breastfeeding individuals
- Should be used under the guidance of a healthcare provider
Summary:
PT 141 is generally well-tolerated when used as prescribed, but nausea, headache, and temporary blood pressure increases are the most common concerns. Proper dosing and medical supervision reduce the risk of adverse effects significantly.
PT 141 Dosage for Women
Standard Dose:
The FDA-approved dosage of PT 141 for women is:
- 1.75 mg via subcutaneous injection, administered as needed, at least 45 minutes before sexual activity.
Timing & Frequency
- Onset of action: 30 to 60 minutes after injection
- Duration of effects: Up to 12 hours
- Dosing limit: Do not exceed one dose in 24 hours, and no more than 8 doses per month
Who It’s For
PT-141 (brand name Vyleesi) is approved for premenopausal women with:
- HSDD (Hypoactive Sexual Desire Disorder) that is:
- Acquired (not lifelong)
- Generalized (not specific to a partner or situation)
It’s not intended for:
- Women with low libido due to relationship issues, medical or psychiatric conditions, or drug side effects
- Postmenopausal women (off-label use only)
Tips for Use
- Inject subcutaneously into the abdomen or thigh
- Avoid injecting into the same site repeatedly
- Store refrigerated; allow to reach room temp before use
- Don’t use alcohol or fatty meals close to administration, as these may worsen side effects like nausea
Important Warnings
- Monitor for nausea (most common side effect); antiemetic use may be needed
- Use caution if you have high blood pressure, as PT 141 may cause transient increases
- Not recommended during pregnancy or breastfeeding
FAQ section for PT 141 (Bremelanotide)
What is PT 141?
PT 141, also known as Bremelanotide, is a synthetic peptide used to treat sexual dysfunction. It works by stimulating melanocortin receptors in the brain, enhancing sexual desire and arousal in both men and women.
How does PT 141 work?
PT 141 targets the central nervous system, not the vascular system like Viagra. It activates melanocortin-4 (MC-4) receptors in the brain, which are linked to sexual arousal, making it effective for both men and women with low libido.
What is the recommended dosage of PT 141 for women?
The FDA-approved dose for women is 1.75 mg, administered via subcutaneous injection, about 45 minutes before sexual activity. Use is limited to one dose per 24 hours and no more than 8 times per month.
Can men use PT 141?
Yes. Although PT 141 is officially approved for women with hypoactive sexual desire disorder (HSDD), many men use it off-label to treat erectile dysfunction or boost libido, especially when PDE5 inhibitors like Viagra are ineffective.
How quickly does PT 141 work?
Effects typically begin within 30 to 60 minutes of injection, with sexual arousal lasting up to 12 hours in some users.
Is PT 141 safe?
PT-141 is generally safe when used as directed, but it may cause side effects such as:
- Nausea
- Headache
- Flushing
- Elevated blood pressure
- Injection site reactions
It should not be used by individuals with uncontrolled hypertension or cardiovascular disease without medical supervision.
What are the common side effects of PT 141?
The most common side effects include:
- Nausea (most frequent)
- Facial flushing
- Headaches
- Vomiting (in higher doses)
- Darkened gums or skin (rare, but possible with repeated use)
How is PT 141 administered?
It is injected subcutaneously, usually in the abdomen or thigh. The nasal spray form exists in research contexts but is not widely used commercially due to reduced effectiveness.
Is PT 141 FDA-approved?
Yes. PT-141 is FDA-approved under the brand name Vyleesi for the treatment of HSDD in premenopausal women.
Can PT 141 be used with other ED medications?
While some users combine PT-141 with drugs like Viagra or Cialis, this is off-label and should only be done under a healthcare provider’s guidance to avoid side effects or interactions.
Where can I buy PT 141?
PT-141 is available by prescription in the U.S. (as Vyleesi) and through compounding pharmacies or research peptide vendors in other regions. Ensure you buy from licensed and reputable sources to avoid unsafe or counterfeit products.
Reviews
There are no reviews yet.